<DOC>
	<DOCNO>NCT02194062</DOCNO>
	<brief_summary>The purpose study compare intranasal fluticasone spray budesonide nasal saline rinse upright head forward position patient functional endoscopic sinus surgery ( FESS ) chronic rhinosinusitis nasal polyposis ( CRSwNP ) measure difference Sinonasal Outcome Test-22 ( SNOT-22 ) score Lund- Kennedy score rigid nasal endoscopy time point 1 week , 3 week , 6 week , 2 month , 4 month , 6 month post-op .</brief_summary>
	<brief_title>Comparison Nasal Steroids After FESS CRSwNP</brief_title>
	<detailed_description>Chronic rhinosinusitis ( CRS ) inflammatory condition line nose sinus last 12 week longer objective evidence mucosal inflammation ( 1 ) . CRSwNP characterize presence bilateral nasal polyp middle meatus . Patients CRSwNP medical therapy fail , often functional endoscopic sinus surgery . Nasal steroids important post-operatively prevent polyp recur . Many study show nasal steroid superior placebo maintain improvement symptom score , SNOT-22 , post-operatively prevent polyp return ( 2 ) . Nasal steroids reduce inflammation locally prevent disease relapse without systemic effect oral steroid . However , consensus nasal steroid delivery method effective treating patient . Traditional nasal spray , fluticasone spray , may deliver medication widely nasal cavity . Budesonide available respule form use instill medication nose . In attempt effectively deliver medication , change patient 's head position prescribe achieve good delivery ( 3 ) . The safety intranasal budesonide , potent steroid fluticasone , establish ( 4 , 5 ) . However , improve efficacy fluticasone nasal spray remain anecdotal head head comparison previously perform . Practice pattern among rhinologists post-operative prescription nasal steroid vary widely . Determining medication/delivery method effective help rhinologists well treat patient prevent symptom , surgery perform , return .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Adult patient FESS CRSwNP within study period 1 . Patients age 18 2 . Concurrent oral corticosteroid use equivalent great 10 mg prednisone use per day 3 . The use medication accelerate clearance systemic cortisol ( Dilantin , rifampin , amphetamine , lithium ) 4 . The use medication inhibit clearance systemic cortisol ( ketoconazole , amphotericin B , bupropion , fluoroquinolones ) 5 . Known hypersensitivity corticosteroid 6 . A personal history Wegener 's Granulomatosis autoimmune disease nasal manifestation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Chronic rhinosinusitis polyp</keyword>
	<keyword>Nasal steroid</keyword>
	<keyword>Functional endoscopic sinus surgery</keyword>
	<keyword>SNOT-22</keyword>
	<keyword>Lund-Kennedy</keyword>
</DOC>